BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23769926)

  • 1. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.
    Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G
    Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.
    Sun XS; Wen J; Li JX; Lai R; Wang YF; Liu HJ; Sheng WL
    Mol Genet Genomics; 2016 Jun; 291(3):1193-203. PubMed ID: 26847828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
    Huang Y; Cheng D; Zhang J; Zhao W
    J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
    Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
    World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
    Park MG; Shin JH; Lee SW; Park HR; Park KP
    J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a functional polymorphism in the MMP-3 gene with Moyamoya Disease in the Chinese Han population.
    Li H; Zhang ZS; Liu W; Yang WZ; Dong ZN; Ma MJ; Han C; Yang H; Cao WC; Duan L
    Cerebrovasc Dis; 2010; 30(6):618-25. PubMed ID: 20948207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
    Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H
    Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of
    Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
    Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
    Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Genetic Variants With Moyamoya Disease in 13 000 Individuals: A Meta-Analysis.
    Wang X; Wang Y; Nie F; Li Q; Zhang K; Liu M; Yang L; Zhang Q; Liu S; Zeng F; Shang M; Liang M; Yang Y; Liu X; Liu W
    Stroke; 2020 Jun; 51(6):1647-1655. PubMed ID: 32390555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease.
    Park YS; Jeon YJ; Kim HS; Han IB; Oh SH; Kim DS; Kim NK
    BMC Neurol; 2014 Oct; 14():180. PubMed ID: 25280484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells.
    Li Z; Liu Y; Li X; Yang S; Feng S; Li G; Jin F; Nie S
    Neurosurg Rev; 2024 May; 47(1):246. PubMed ID: 38811382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China.
    Sun X; Luo M; Li J; Lai R; Lin J; Wang Y; Xu X; Wu S; Sheng W
    Mol Genet Genomics; 2020 May; 295(3):635-643. PubMed ID: 32020275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
    Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.
    Ma J; Liu Y; Ma L; Huang S; Li H; You C
    Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
    Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
    Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
    PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease.
    Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T
    Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.